Kemin Industries launches DailyZz safe and natural sleep aid

Image source: PR Newswire

DailyZz contains a propriety blend rich in naturally occurring polyphenols for safe and natural nightly sleep

The US based Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has launched its newest product for human health and nutrition, DailyZz, an ingredient containing a propriety blend rich in naturally occurring polyphenols for safe and natural nightly sleep.

A recent human clinical trial has shown that in as early as one week, DailyZz promotes better quality sleep and improves next-day functioning in healthy adults who have occasional sleep complaints.

In the 100-person study, sleep quality and daytime functioning benefits showed improvement in both objective and subjective measures. The study used multiple rigorous testing methods, including computerized performance testing and validated sleep diary surveys – the gold standard for assessing the subjective sleep experience – to evaluate the effects of supplementation of DailyZz on sleep and next-day performance.

Participants in the 30-day study received either 485 milligrams of DailyZz to take 30 minutes before bed or a placebo. Those taking DailyZz nightly showed significant improvement in their quality of sleep, as well as better concentration, reaction time and visual recall and processing. The participants taking DailyZz also showed improved judgment in a risk-taking scenario after a night of quality sleep. 

The global sleep market illustrates just how much today’s busy consumers are looking for a good night’s rest. With a compound annual growth rate (CAGR) of eight percent and global retail sales projected to reach USD$2.3 billion by 2025, the market reflects the consumer need for sleep-support supplementation.

Read Previous

Research finds spiked cholesterol levels in youth during COVID-19

Read Next

KIND introduces diet and nutrition platform RD Connect

Leave a Reply